Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.

Saved in:
Bibliographic Details
Title: Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.
Authors: Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Center for Cancer Immunotherapy, San Francisco, California., Nabet BY; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Chaudhuri AA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Wells DK; Parker Center for Cancer Immunotherapy, San Francisco, California., Dunphy MPS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Chabon JJ; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Liu CL; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Hui AB; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Luo J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Preeshagul IR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Moding EJ; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Almanza D; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Bonilla RF; Department of Radiation Oncology, Stanford University, Stanford, California., Sauter JL; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Choi H; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Tenet M; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Abu-Akeel M; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Perez Johnston R; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Yoo CH; Department of Radiation Oncology, Stanford University, Stanford, California., Ko RB; Department of Radiation Oncology, Stanford University, Stanford, California., Stehr H; Department of Pathology, Stanford University, Stanford, California., Gojenola L; Department of Pathology, Stanford University, Stanford, California., Wakelee HA; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Padda SK; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Neal JW; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Chaft JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Merghoub T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Parker Center for Cancer Immunotherapy, San Francisco, California.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Alizadeh AA; Stanford Cancer Institute, Stanford University, Stanford, California. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Diehn M; Department of Radiation Oncology, Stanford University, Stanford, California. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.; Stanford Cancer Institute, Stanford University, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jun 15; Vol. 26 (12), pp. 2849-2858. Date of Electronic Publication: 2020 Feb 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-19-3418